Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study

Authors: Andrew Östör, Eugen Feist, Prodromos Sidiropoulos, Jérôme Avouac, Martin Rebella, Rajaie Namas, Erin McDearmon-Blondell, Tianming Gao, Ivan Lagunes-Galindo, Sander Strengholt, Devy Zisman, Suzan Attar

Source: Arthritis Research & Therapy, Vol 27, Iss 1, Pp 1-14 (2025)

Subject Terms: Effectiveness, Real-world, Rheumatoid arthritis, Safety, Upadacitinib, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/19b21f72da754ea0a7c363d230f75d7f

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study

Authors: Filip Van den Bosch, Atul Deodhar, Denis Poddubnyy, Walter P. Maksymowych, Désirée van der Heijde, Tae-Hwan Kim, Mitsumasa Kishimoto, Xenofon Baraliakos, Xianwei Bu, Ivan Lagunes-Galindo, In-Ho Song, Peter Wung, Koji Kato, Anna Shmagel

Source: Arthritis Research & Therapy, Vol 27, Iss 1, Pp 1-13 (2025)

Subject Terms: Axial spondyloarthritis, Disease activity, Inflammation, Janus kinase inhibitor, Safety, Upadacitinib, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/f031cb37c3d749029e43dbdcd5ee759c

Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study

Authors: Xenofon Baraliakos, Désirée van der Heijde, Joachim Sieper, Robert Davies Inman, Hideto Kameda, Walter Peter Maksymowych, Ivan Lagunes-Galindo, Xianwei Bu, Peter Wung, Koji Kato, Anna Shmagel, Atul Deodhar

Source: Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-13 (2024)

Subject Terms: Ankylosing spondylitis, Radiographic axial spondyloarthritis, Biologic DMARD, Inadequate response, Open-label extension, Refractory, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/1259403985ce47a0a402e64210800be8

Disease activity improvements with optimal discriminatory ability between treatment arms: applicability in early and established rheumatoid arthritis clinical trials

Authors: Josef Smolen, Roy Fleischmann, Daniel Aletaha, Yihan Li, Yijie Zhou, Iain Sainsbury, Ivan Lagunes Galindo

Source: Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-8 (2019)

Subject Terms: Rheumatoid arthritis, Disease activity, Biologicals, Clinical trial, Diseases of the musculoskeletal system, RC925-935

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s13075-019-2005-9; https://doaj.org/toc/1478-6362

Access URL: https://doaj.org/article/d254bfad6e1445fa99390a43a5f07e76